ServicenavigationHauptnavigationTrailKarteikarten

Forschungsstelle
INNOSUISSE
Projektnummer
13750.1;12 PFFLE-LS
Projekttitel
Antibody-based therapy for type-2 diabetes
Projekttitel Englisch
Antibody-based therapy for type-2 diabetes

Texte zu diesem Projekt
 DeutschFranzösischItalienischEnglisch
Kurzbeschreibung
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
Anzeigen

Erfasste Texte


KategorieText
Kurzbeschreibung
(Deutsch)
Antibody-based therapy for type-2 diabetes
Kurzbeschreibung
(Englisch)
Antibody-based therapy for type-2 diabetes
Abstract
(Deutsch)
The project focuses on the development of an immunotherapy targeting toxic aggregates of islet amyloid polypeptide which are associated with the loss of pancreatic beta-cells in type-2 diabetes patients. Combining Neurimmune¿s expertise in the discovery and validation of human antibodies and academic partners' know-how in diabetes and amyloidosis research, the joint program is aimed at providing in vivo proof-ofconcept for this novel therapeutic strategy for type-2 diabetes.
Abstract
(Englisch)
The project focuses on the development of an immunotherapy targeting toxic aggregates of islet amyloid polypeptide which are associated with the loss of pancreatic beta-cells in type-2 diabetes patients. Combining Neurimmune¿s expertise in the discovery and validation of human antibodies and academic partners' know-how in diabetes and amyloidosis research, the joint program is aimed at providing in vivo proof-ofconcept for this novel therapeutic strategy for type-2 diabetes.